- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Age bows out as factor forrecurrence in DCIS patients
Younger women with ductal carcinoma insitu have traditionally been held to have ahigher risk of recurrence than older womenwith the condition. A new study from FoxChase Cancer Center inPhiladelphia, however,challenges this view.
Younger women with ductal carcinoma in situ have traditionally been held to have a higher risk of recurrence than older women with the condition. A new study from Fox Chase Cancer Center in Philadelphia, however, challenges this view.
Dr. Aruna Turaka and colleagues examined 440 patients with DCIS. All patients received whole-breast radiotherapy, and 95% received additional radiation to the excision site. Study results showed no statistically significant difference between younger and older patients when it came to recurrences.
Findings were released at the 2008 American Society for Therapeutic Radiology and Oncology meeting. "There is a trend toward increased risk in younger women, but it was not significant enough to show that they do badly compared with the older women," Turaka told Diagnostic Imaging.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
